Disseminated paracoccidioidomycosis under biological therapy

Authors

  • Jaime A Ibarra-Burgos Internal medicine, Universidad CES Escuela de Medicina, Medellín, Colombia https://orcid.org/0000-0002-3928-9310
  • Simón Correa-Sierra Internal medicine, Universidad CES Escuela de Medicina, Medellín, Colombia https://orcid.org/0000-0002-0065-6654
  • Sergio A Londoño-Tabares Hospital Alma Mater de Antioquia, Clínica CES, Medellín, Colombia

DOI:

https://doi.org/10.3855/jidc.18939

Keywords:

paracoccidioidomycosis, immunosuppression, opportunistic, infections

Abstract

Introduction: Paracoccidioidomycosis is an endemic mycotic infection caused by Paracoccidioides spp., prevalent in Central and South American countries. Anti-tumor necrosis factor (TNF) alpha agents, commonly used for autoimmune diseases, increase the risk of severe infections. We present a case of anti-TNF alpha-related paracoccidioidomycosis in a 71-year-old male farmer from Colombia.

Case presentation: The patient had oral lesions and chronic cough. A biopsy showed granulomatous inflammation with multinucleated giant cells but no microorganisms. Negative microbiological stains and tests for other infections prompted further investigations. A positive serum immunodiffusion test for Paracoccidioides antibodies at a 1:256 titer led to mediastinoscopy and lung biopsy, which revealed budding yeast in a “captain’s wheel” formation. Treatment with liposomal amphotericin B and itraconazole was initiated.

Conclusions: This case highlights the risk of opportunistic infections under anti-TNF alpha therapy and raises awareness of paracoccidioidomycosis associations. Early diagnosis and management are essential for better patient outcomes.

Downloads

Published

2025-06-30

How to Cite

1.
Ibarra-Burgos JA, Correa-Sierra S, Londoño-Tabares SA (2025) Disseminated paracoccidioidomycosis under biological therapy. J Infect Dev Ctries 19:987–989. doi: 10.3855/jidc.18939

Issue

Section

Case Reports